BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20923588)

  • 1. Classification of evidence in decision-analytic models of cost-effectiveness: a content analysis of published reports.
    Paisley S
    Int J Technol Assess Health Care; 2010 Oct; 26(4):458-62. PubMed ID: 20923588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How should cost-effectiveness analysis be used in health technology coverage decisions? Evidence from the National Institute for Health and Clinical Excellence approach.
    Williams I; Bryan S; McIver S
    J Health Serv Res Policy; 2007 Apr; 12(2):73-9. PubMed ID: 17407655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health technology assessment in the cost-disutility plane.
    Eckermann S; Briggs A; Willan AR
    Med Decis Making; 2008; 28(2):172-81. PubMed ID: 18356312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis and formulary decision making in England: findings from research.
    Williams IP; Bryan S
    Soc Sci Med; 2007 Nov; 65(10):2116-29. PubMed ID: 17698271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NICE's use of cost effectiveness as an exemplar of a deliberative process.
    Culyer AJ
    Health Econ Policy Law; 2006 Jul; 1(Pt 3):299-318. PubMed ID: 18634698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.
    Hernández MA; Vázquez-Polo FJ; González-Torre FJ; Bas EM
    Int J Technol Assess Health Care; 2009 Oct; 25(4):537-45. PubMed ID: 19845984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making health technology assessment information available for decision making: the development of a Thai database.
    Kapol N; Maitreemit P; Chalongsuk R; Amrumpai Y; Sribundit N; Thavorncharoensap M; Chaikledkaew U; Teerawattananon Y
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S8-10. PubMed ID: 19253482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of cost-effectiveness analysis in health care decision-making.
    Magel JS
    Physician Exec; 1990; 16(3):31-2. PubMed ID: 10113233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness acceptability curves--caveats quantified.
    Jakubczyk M; Kamiński B
    Health Econ; 2010 Aug; 19(8):955-63. PubMed ID: 19688780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of clinical effects.
    Teerawattananon Y; Thavorncharoensap M; Mohara A
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S38-42. PubMed ID: 19253486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic evaluations using decision analytic modeling. Principles and practices--utilization of a checklist to their development and appraisal.
    Soto J
    Int J Technol Assess Health Care; 2002; 18(1):94-111. PubMed ID: 11987445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' views of explicit rationing: what are the implications for health service decision-making?
    Devlin N; Appleby J; Parkin D
    J Health Serv Res Policy; 2003 Jul; 8(3):183-6. PubMed ID: 12869346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap.
    Legood R; Wolstenholme J; Gray A
    Health Policy; 2009 Feb; 89(2):193-200. PubMed ID: 18619702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost/benefit analysis-another dimension.
    Hess OW
    Med Instrum; 1982; 16(1):76-7. PubMed ID: 6801445
    [No Abstract]   [Full Text] [Related]  

  • 17. Expected value of information and decision making in HTA.
    Eckermann S; Willan AR
    Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regarding probabilistic analysis and computationally expensive models: necessary and required?
    Caro JJ; Getsios D; Möller J
    Value Health; 2007; 10(4):317-8; author reply 319. PubMed ID: 17645686
    [No Abstract]   [Full Text] [Related]  

  • 19. Health economic evaluations: how to find them.
    Alton V; Eckerlund I; Norlund A
    Int J Technol Assess Health Care; 2006; 22(4):512-7. PubMed ID: 16984686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical trials of cost effectiveness in technology evaluation.
    Valk PE
    Q J Nucl Med; 2000 Jun; 44(2):197-203. PubMed ID: 10967629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.